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Sodium Lactobionate Sucrose Solution for Canine Liver and 
Kidney Preservation 
Y. Zhu, H. Furukawa, K. Nakamura, I. Hamamoto, Y. Wu, R. Xiaoshan, R. Venkataramanan, S. Todo, 
and T.E. Starzl 
EVEN though the University of Wisconsin (UW) solu-
tion developed by Belzer and Southard I in 1988 has 
markedly prolonged the preservation time of most of the 
solid organs.2 •3 there still have been many efforts to 
improve the quality of UW solution.4-6 Recently. Toku-
naga et aJ1 developed a new solution. sodium lactobionate 
sucrose (SLS) solution. which has been shown to be 
superior to UW solution in rat liver preservation. In the 
SLS solution, sucrose is substituted for the raffinose in the 
UW solution and the SLS solution has an extracellular 
type electrolyte composition. Additionally. chlorproma-
zine (CPZ) is added to SLS solution to maintain the 
microvasculature and membrane integrity. In the present 
study. we compared the performance of these solutions 
using canine liver and kidney transplantation models. 
MATERIALS AND METHODS 
Animals and Surgical Procedures 
Female beagle dogs (9 to 11 kg) and mongrel dogs (18 to 23 kg) 
were used for liver and kidney transplantation. respectively. All of 
the dogs were fasted 12 hours before operation. The dogs were 
anesthetized with 25 mg/kg of IV sodium thiopental for induction. 
maintained with isoflurane. and oxygenated under mechanical 
ventilation. 
Liver Transplantation 
Orthotopic liver transplantation was performed by a method 
described previously. 8-10 The donor livers were Hushed in situ 
with either UW solution (group I. n = 7) or SLS solution 
containing I mglL of CPZ (SLS) (group 2, n = 7). One liter of 
preservation solution was perfused through the portal vein and 
500 mL through the aorta. The livers were stored for 24 hours in 
the same solution prior to transplantation. J 
Graft weight was measured before and after preservation. The 
occurrences of hypotension and outflow block after reperfusion 
were determined. Hepatic artery and the portal vein blood Hows 
(before harvesting and at I hour and 2 hours after uncIamping) 
were measured. Following transplantation, serum glutamic oxa-
loacetic transaminase (SGOT) , lactate dehydrogenase (LDH). 
glucose. and total bilirubin were measured daily. All of the 
surviving animals were killed at 14 days. Autopsies were per-
formed immediately on animals that died before 14 days. Liver 
tissue was taken before transplant. 2 hours after transplant, and at 
autopsy. 
Kidney Transplantation 
The technique used for kidney autotransplantation was described 
previously.2 The renal artery was flushed with 200 mL of cold 
heparinized lactated Ringer's solution, foHowed by 200 mL of cold 
Table 1. Animal SurvIval After LIver or KIdney TransplantatIon 
WHh UW or SLS SolutIon 
Uver 
Group 1 (UW) 
Group 2 (SLS) 
Kidney 
Group 3 (UW) 








~rombosis of the renal artery. 
Survival (d) 
1: 14, 14, 14, 14, 14, 14 
1: 1: 2: 2: 9,t 14,14 
15,15,15, 15, 15, 15 
5,; 15,15,15,15,15 
UW (group 3, n = 6) or SLS solution (group 4. n = 6). The kidneys 
were stored in the same solution for 72 hours. 
Graft weight was measured before and after preservation. Renal 
arterial blood flow was measured immediately before harvesting, 
and at I and 2 hours after revascularization. Graft function was 
estimated by urine output at I and 2 hours after unciamping and by 
daily serum creatinine (Cr) levels. All of the animals that survived 
for 15 days were killed. Autopsies were performed immediately on 
dogs that died before 15 days. A section of kidney was obtained 
for histopathologic analysis. 
RESULTS 
Our general impression was that in situ flushing of the liver 
and the kidney was faster and smoother with SLS solution 
than UW solution. 
Liver 
Six of the seven dogs (86%) in group 1 survived for 14 
days. whereas only two of the seven dogs (28%) in group 
2 survived for the same period (Table O. Reperfusion of 
group 1 grafts was similar to that of immediately trans-
planted grafts. Disturbance of reperfusion. occurrence of 
outflow block, and poor bile production were rarely found 
in group 1 animals. but common in group 2 animals. Grafts 
in both groups I and 2 lost similar amounts of weight 
(-0.6% to -12.5%) during the preservation period. He-
patic artery and portal vein blood flows at 1 and 2 hours 
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SLS SOLUTION 
Table 2. Liver Function 
1 h 6h 24 h 
SGOT (U,'L) 
Group 1 2,037 :t 1 ,021 2,151 :t 822 1,798 :t 1,233 
Group 2 2,689 :t 1 ,525 2,802 :t 1,605 836:t 836 
LDH (U/L) 
Group 1 1,357 :t 645 923:t 348 614 ± 321 
Group 2 2,442 ± 1,159 1,365 :t 885 836 ± 764 
Glucose (mgldL) 
Group 1 200 ± 58 226 ± 147 93.2 ± 33.9 
Group 2 324:t 150 217 ± 155 107 ± 85 
after graft reperfusion were not significantly different be-
tween the groups. However, 6 hours after liver transplan-
tation, group 2 animals exhibited higher SGOT and LDH 
levels than group I (Table 2). No remarkable histopatho-
logic differences were noted between two groups in pre-
transplant, 2-hour posttransplant, and autopsy samples. 
Kidney 
All of the group 3 dogs survived for 15 days (100%), while 
5 of the 6 group 4 dogs survived for 15 days (83.3%) (Table 
3). Graft weight loss during the preservation period was 
similar between groups (-8% to -31%). Group 3 urine 
output for the first 2 hours after unclamping was higher 
than group 4 (658 ± 582 vs 385 ± 360 ~rh/g kidney), but 
it was not statistically significant (Table 3). Kidneys in 
groups 3 and 4 reperfused well after reimplantation, but the 
arterial blood flow was slightly lower than the value before 
harvesting for both groups. No histopathologic differences 
were seen in the grafts of either group. Group 4 posttrans-
plant Cr levels were lower than group 3, with day 2 Cr 
being significantly lower (Table 3). 





10.98 :t 5.36 
5.27 :t 1.53* 
• P < .05 va group 3 by Student's I test. 
5d 
7.05:t 3.05 
6.92 ± 4.23 
15d 
3.92:t 4.1 
2.75 :t 0.7 
1619 
SUMMARY 
With 24-hour preservation of canine liver, SLS solution 
showed inferior animal survival [0 UW soimion. The 
lactobionale, raffinose, glutathione, and hydroxyelhyl 
starch in UW solution have been shown to be important 
for liver preservation. I 1.12 However, our results suggest 
that sucrose should not be substituted for raffinose for the 
preservation of livers. 
In contrast to the liver, SLS solution performed the 
same or even better than UW solution for kidney preser-
vation. The substitution of sucrose for raffinose, along with 
the addition of CPZ has either no effect or a slightly 
positive effect on kidney preservation. 12.13 
In conclusion, SLS solution may be a suitable solution 
for preserving canine kidneys, but is not suitable for liver 
preservation. These findings suggest that future develop-
ment of preservation solutions should be focused on the 
needs of specific organs and not toward a generic, all 
encompassing preservation solution. 
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